Peptide profile · Hormone Support
Ganirelix
Fast-acting GnRH antagonist that stops premature ovulation during fertility treatment
Written & reviewed by Michael Carroll · Research, Peptide Initiative
Typical dose
250 mcg
Half-life
10-12 hours
Bioavailability
~91% (subcutaneous injection)
Molecular weight
1570.4 g/mol
Evidence level
Strong human trials
01 · Compound profile
Scientific & efficacy data
Molecular formula
C80H113ClN18O13
Primary benefits
Allows doctors to control exactly when ovulation happens
Improves success rates in IVF cycles
Prevents premature LH surge that can ruin egg quality
Organon (later Schering-Plough)
Amino acid sequence
Ac-D-2-Nal-D-4-Cl-Phe-D-3-Pal-Ser-Tyr-D-Arg-Leu-Arg-Pro-Gly-NH202 · Dosing
How much do I take?
250 mcg · once daily during the mid-to-late follicular phase
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
Best time to take
Administer Ganirelix at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Ganirelix injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Ganirelix should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
＋ Increase if
- +You've tolerated the current dose for the recommended period without significant side effects
- +Therapeutic goals haven't been met at the current dose level
- +Your healthcare provider recommends dose escalation based on your response
- +Lab work or clinical assessments support a higher dose
－ Decrease if
- −Side effects are bothersome or impacting daily life despite management strategies
- −You experience any signs of an adverse reaction
- −Lab results indicate the need for dose reduction
- −Your healthcare provider recommends a lower dose based on your response
✓ Signs of right dose
- ✓Therapeutic goals being met with minimal side effects
- ✓Stable and consistent response to treatment
- ✓Lab values or clinical markers trending in the right direction
- ✓Good tolerance with manageable or absent side effects
Dosing Calculator
Calculate Your Exact Dose
Step 1: Peptide Weight
Find the weight printed on your peptide vial label
Look here!
The peptide weight is printed on the label
Look here!
The weight is on the label
Select Weight
Look for a number followed by 'mg' on the vial label (e.g., 5mg, 10mg)
03 · Suitability
Is this right for me?
Best for improving ivf or icsi success rates & preventing premature ovulation during egg retrieval cycles
Best for
Improving IVF or ICSI success rates
Ganirelix is particularly well-suited for individuals focused on improving ivf or icsi success rates. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Preventing premature ovulation during egg retrieval cycles
Ganirelix is particularly well-suited for individuals focused on preventing premature ovulation during egg retrieval cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Controlling ovarian stimulation in women with unpredictable cycles
Ganirelix is particularly well-suited for individuals focused on controlling ovarian stimulation in women with unpredictable cycles. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Ganirelix with similar peptides to find the best fit for your goals.
04 · Administration
How do I use it?
Subcutaneous injection
Reconstitution — what you need
Example
Add the recommended volume of bacteriostatic water to the Ganirelix vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.
Your dose of Ganirelix is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Technique
- 01Wash your hands thoroughly with soap and water before handling supplies
- 02Clean the injection site with an alcohol swab and let it air dry completely
- 03Pinch a fold of skin at the chosen injection site
- 04Insert the needle at a 45-90 degree angle (depending on needle length and body composition)
- 05Inject the medication slowly and steadily over 5-10 seconds
- 06Release the skin fold and remove the needle, applying gentle pressure with a clean swab
- 07Rotate injection sites to prevent tissue irritation or lipodystrophy
- 08Dispose of the needle safely in a sharps container—never recap or reuse needles
Storage · before reconstitution
Store Ganirelix in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Storage · after reconstitution
Once reconstituted, Ganirelix should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation
Sample daily schedule
05 · Safety
Is it safe?
7 common side effects · 2 serious
Ganirelix carries an excellent safety record from over 10,000 patients in FDA approval trials and 25+ years of clinical fertility practice. The antagonist mechanism avoids the flare effect seen with GnRH agonists, making it safer for women with diminished ovarian reserve. Injection site reactions are the most common issue (20-40% of patients), though typically mild bruising rather than systemic toxicity. The rapid 1-2 hour onset and quick clearance mean side effects resolve quickly if dosing is adjusted.
Ganirelix safety is well-established through Phase 3 multicenter trials (Organon studies, 1995-1999) and post-marketing surveillance of over 250,000 treatment cycles. ASRM and ESHRE guidelines recommend it as a standard first-line antagonist for IVF cycles based on efficacy and tolerability data. Pivotal trials showed no clinically significant abnormalities in liver, kidney, or hematologic parameters even with daily dosing for 2+ weeks.
Common side effects · experienced by some users
Stop and seek help if
- ×Severe or worsening side effects that don't improve with dose adjustment or supportive care
- ×Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- ×Your healthcare provider recommends discontinuation based on your clinical response
- ×Development of any new medical condition that may be contraindicated with Ganirelix
- ×Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- ×Abnormal lab results or clinical markers that suggest adverse effects
Ganirelix should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- ✓FSH (follicle-stimulating hormone) for egg growth — May be used together under medical guidance.
- ✓hCG (human chorionic gonadotropin) to trigger final egg maturation — May be used together under medical guidance.
- ✓GnRH agonists in certain protocol variations — May be used together under medical guidance.
With medications
- !Other GnRH antagonists (like cetrorelix) in the same cycle — Use with caution—discuss with your healthcare provider.
- !Certain herbal supplements that affect hormones — Use with caution—discuss with your healthcare provider.
With supplements
- ✓Multivitamins — Generally safe to take alongside Ganirelix. Space doses apart if taking oral formulations to ensure optimal absorption.
- ✓Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
06 · Effectiveness
How do I know it's working?
Strong human trials · first signs day 1-4
Evidence level
Strong human trials
(Phase 3 or FDA approved)
How it works
Ganirelix works like a lock that prevents the key (GnRH) from opening the door to egg release. Unlike agonists that initially stimulate before shutting down, ganirelix immediately blocks the GnRH receptors, preventing the LH surge that triggers ovulation. During IVF, this gives doctors precise control over when eggs mature and can be retrieved, dramatically improving success rates.
Ganirelix is a synthetic decapeptide GnRH antagonist with modifications including N-terminal acetylation, D-2-naphthylalanine at position 2, and chlorinated aromatic substitutions that provide competitive antagonism at pituitary GnRH receptors. Unlike GnRH agonists, ganirelix provides immediate receptor blockade without initial stimulation, achieving suppression of LH and FSH within hours. During controlled ovarian hyperstimulation, ganirelix prevents premature LH surge (which would trigger ovulation prematurely), allowing synchronized egg maturation. The drug is administered daily via subcutaneous injection starting mid-cycle, with onset within 1-2 hours and offset within 24 hours of the final dose. This reversible antagonism provides precise control critical for IVF cycle synchronization, enabling predictable timing of oocyte retrieval and significantly improving fertilization and implantation rates.
What to expect
Day 1-4
What you might notice
- •Start FSH injections to stimulate egg growth
- •Not yet started
What's normal
- •Initial response to Ganirelix is beginning at the cellular level
- •Different individuals experience Ganirelix's onset at different rates
- •Transient systemic effects from initial Ganirelix exposure are common
What's next
- →Maintain consistent Ganirelix administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Day 5-6
What you might notice
- •When leading follicle reaches 14mm, start daily ganirelix injections
- •Begin 250 mcg once daily
What's normal
- •Ganirelix is achieving sufficient receptor engagement
- •Initial mechanism of Ganirelix is taking effect
- •Early transient effects from Ganirelix administration are resolving
What's next
- →Maintain consistent Ganirelix administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Day 7-12
What you might notice
- •Continue both FSH and ganirelix, with frequent monitoring via ultrasound
- •Continue same dose unless adjusted by doctor
What's normal
- •Ganirelix is achieving sufficient receptor engagement
- •Initial mechanism of Ganirelix is taking effect
- •Early transient effects from Ganirelix administration are resolving
What's next
- →Maintain consistent Ganirelix administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Day 10-14
What you might notice
- •When 2-3 follicles reach 18mm, receive hCG trigger shot to finalize egg maturation
- •Take final dose same evening as trigger
What's normal
- •Ganirelix is achieving sufficient receptor engagement
- •Initial mechanism of Ganirelix is taking effect
- •Early transient effects from Ganirelix administration are resolving
What's next
- →Maintain consistent Ganirelix administration as prescribed
- →Document subjective effects and physical markers daily
- →Schedule a check-in with your provider about initial observations
Day 11-15
What you might notice
- •Egg retrieval procedure 34-36 hours after hCG trigger
- •Stopped - cycle complete
What's normal
- •Ganirelix response patterns are emerging
- •Initial Ganirelix response is consistent with mechanism expectations
- •Early tolerance development to Ganirelix is not expected
What's next
- →Assess whether Ganirelix response aligns with expectations
- →Plan next steps based on initial Ganirelix tolerance and response
- →Establish baseline monitoring for Ganirelix response tracking
Signs it's working · Treatment Response
- ✓Improvement in the primary symptoms or condition being treated
- ✓Positive changes in relevant lab values or clinical markers
- ✓Consistent, stable response to Ganirelix over time
- ✓Reduction in symptom frequency or severity
Signs it's working · General Well-being
- ✓Improved energy levels and daily functioning
- ✓Better quality of life related to the treated condition
- ✓Manageable or absent side effects indicating good tolerance
- ✓Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- •Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- •Insufficient time at target dose—most compounds need several weeks to show full benefits
- •Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- •Individual variation in response—genetics, metabolism, and other factors affect outcomes
- •Underlying conditions or medications interfering with absorption or effectiveness
- •Improper storage leading to degraded product—always verify proper storage conditions
Key research
07 · Questions
Frequently asked
How fast does ganirelix work?+
Ganirelix starts suppressing LH levels within 1-2 hours of injection. Full suppression is achieved within 24 hours, making it much faster than GnRH agonists that can take 2-3 weeks to work.
Why is blocking LH so important for IVF?+
Your body naturally releases eggs on its own schedule through an LH surge. In IVF, doctors need to control the timing to retrieve mature eggs. Without ganirelix, the LH surge would release eggs before they're optimally mature, ruining the cycle. Ganirelix gives doctors complete control.
How is ganirelix different from cetrorelix?+
Both are GnRH antagonists, but studies show cetrorelix may provide slightly better LH suppression and lower OHSS risk, while ganirelix works equally well for most patients and may be faster-acting for some. Your doctor chooses based on your situation.
Are the injections painful?+
Most patients describe them as relatively painless since they're small needles used for subcutaneous (under the skin) injection. However, repeated injections can cause bruising. Rotating sites and using ice can minimize discomfort.
Can ganirelix affect pregnancy if I'm already pregnant?+
Ganirelix should NOT be used if you're pregnant or suspect you are. Always do a pregnancy test before starting a new IVF cycle. If you become pregnant during treatment, stop immediately and contact your doctor.
What happens if I miss a dose?+
Take the missed dose as soon as you remember, unless it's almost time for your next dose. Missing a single dose might allow an LH surge, potentially compromising that cycle. Call your fertility clinic immediately if you miss a dose.
Can I use ganirelix at home?+
Yes! Ganirelix comes in a pre-filled syringe that's easy to self-inject at home. Most patients inject into the abdomen or thigh. Your fertility clinic will teach you the technique before your cycle starts.
How many eggs does ganirelix help retrieve?+
Ganirelix doesn't determine egg quantity - FSH does that. Ganirelix's job is preventing premature ovulation so those eggs can be retrieved when ready. Studies show it helps increase the percentage of mature eggs (which improves quality).
08 · Further reading
History & related research
History · since 1999
The hormone brake for baby-making breakthroughs
A small protein hormone that stops the body from releasing eggs too early during fertility treatment. It gives doctors perfect timing control for IVF.
Read the full history of Ganirelix